| Preface |
|
xiii | |
| Acknowledgments |
|
xvii | |
| Section 1 Allergy/Immunology and Rheumatology |
|
|
1 Efficacy of Immunoglobulin Plus Prednisolone in Prevention of Coronary Artery Abnormalities in Kawasaki Disease (RAISE Study) |
|
|
3 | (8) |
|
|
| Section 2 Behavioral |
|
|
2 Measles, Mumps, and Rubella Vaccination and Autism |
|
|
11 | (6) |
|
|
|
|
|
3 Treatment for Adolescents with Depression Study (TADS) |
|
|
17 | (8) |
|
|
|
4 The Muitimodal Treatment Study of Children with Attention Deficit/Hyperactivity Disorder (MTA) |
|
|
25 | (10) |
|
|
|
|
| Section 3 Cardiology |
|
|
5 Pharmacologic Closure of a Patent Ductus Arteriosus in Premature Infants |
|
|
35 | (4) |
|
|
|
6 The Relation of Overweight to Cardiovascular Risk Factors among Children and Adolescents: The Bogalusa Heart Study |
|
|
39 | (8) |
|
|
| Section 4 Dermatology |
|
|
7 Propranolol versus Prednisolone for Symptomatic Proliferating Infantile Hemangiomas: A Randomized Clinical Trial |
|
|
47 | (8) |
|
|
| Section 5 Endocrinology |
|
|
8 Risk Factors for Cerebral Edema in Children with Diabetic Ketoacidosis |
|
|
55 | (8) |
|
|
| Section 6 ENT |
|
|
9 A Trial of Early Ear Tube Placement in Children with Persistent Otitis Media |
|
|
63 | (8) |
|
|
|
|
| Section 7 General Pediatrics |
|
|
10 Maintenance IV Fluid Requirements |
|
|
71 | (6) |
|
|
|
11 Predischarge Serum Bilirubin to Predict Significant Hyperbilirubinemia in Newborns |
|
|
77 | (6) |
|
|
|
12 Sudden Infant Death Syndrome Risk Factors: The Chicago Infant Mortality Study |
|
|
83 | (4) |
|
|
|
13 Treatment of Acute Otitis Media in Children |
|
|
87 | (6) |
|
|
|
|
|
14 The Human Papillomavirus Vaccine: The Future II Trial |
|
|
93 | (6) |
|
|
|
|
|
15 Evidence of Decrease in Vaccine-Type Human Papillomavirus (HPV) and Herd Protection in Adolescents and Young Women |
|
|
99 | (6) |
|
|
|
16 Effects of Lead Exposure in Childhood |
|
|
105 | (8) |
|
|
| Section 8 Hematology |
|
|
17 Iron Supplementation for Breastfed Infants |
|
|
113 | (6) |
|
|
|
18 Transfusion Strategies for Patients in Pediatric Intensive Care Units |
|
|
119 | (6) |
|
|
|
19 Prophylactic Penicillin in Sickle Cell Anemia |
|
|
125 | (8) |
|
|
| Section 9 Infectious Disease |
|
|
20 Empiric Antimicrobial Therapy for Skin and Soft-Tissue Infections |
|
|
133 | (4) |
|
|
|
21 Infants at Low Risk for Serious Bacterial Infection |
|
|
137 | (6) |
|
|
|
22 Outpatient Treatment of Febrile Infants at Low Risk for Serious Bacterial Infection |
|
|
143 | (8) |
|
|
|
23 Outpatient Treatment of Selected Febrile Infants without Antibiotics |
|
|
151 | (8) |
|
|
|
24 Neonatal Fever without a Source |
|
|
159 | (6) |
|
|
|
25 Serious Bacterial Infections and Viral Infections in Febrile Infants |
|
|
165 | (6) |
|
|
|
26 Chest Radiograph and Lower Respiratory Tract Infection |
|
|
171 | (6) |
|
|
|
27 Vidarabine Therapy of Neonatal Herpes Simplex Virus Infection |
|
|
177 | (6) |
|
|
|
28 Early Reversal of Pediatric and Neonatal Septic Shock |
|
|
183 | (6) |
|
|
|
29 Reduction of Vertical Transmission of Human Immunodeficiency Virus |
|
|
189 | (6) |
|
|
|
30 Palivizumab Prophylaxis against Respiratory Syncytial Virus in High-Risk Infants |
|
|
195 | (6) |
|
|
|
31 The Spectrum of Bronchiolitis |
|
|
201 | (6) |
|
|
|
32 Preventing Early-Onset Neonatal Group B Streptococcal Disease |
|
|
207 | (8) |
|
|
| Section 10 Neonatology |
|
|
33 Apgar Scoring of Infants at Delivery |
|
|
215 | (4) |
|
|
|
34 Prophylactic Treatment with Human Surfactant in Extremely Preterm Infants |
|
|
219 | (6) |
|
|
| Section 11 Nephrology |
|
|
35 Oral versus Initial Intravenous Antibiotics for Urinary Tract Infection in Young Febrile Children |
|
|
225 | (6) |
|
|
|
36 Identifying Children with Minimal Change Disease |
|
|
231 | (6) |
|
|
|
37 Chronic Renal Disease Following Poststreptococcal Glomerulonephritis |
|
|
237 | (8) |
|
|
| Section 12 Neurology |
|
|
38 Antipyretic Agents for Preventing Febrile Seizure Recurrence |
|
|
245 | (6) |
|
|
|
39 Febrile Seizures and Risk for Epilepsy |
|
|
251 | (6) |
|
|
|
40 Seizure Recurrence after First Unprovoked Afebrile Seizure |
|
|
257 | (6) |
|
|
|
41 Mortality and Childhood-Onset Epilepsy |
|
|
263 | (6) |
|
|
|
42 Identifying Children with Low-Risk Head Injuries Who Do Not Require Computed Tomography |
|
|
269 | (8) |
|
|
|
|
| Section 13 Oncology |
|
|
43 Health-Related Quality of Life among Children with Acute Lymphoblastic Leukemia |
|
|
277 | (8) |
|
|
| Section 14 Ophthalmology |
|
|
44 Treatment of Acute Conjunctivitis in Children |
|
|
285 | (6) |
|
|
|
45 Screening for Amblyopia |
|
|
291 | (8) |
|
|
| Section 15 Orthopedics |
|
|
46 Differentiation between Septic Arthritis and Transient Synovitis of the Hip in Children |
|
|
299 | (8) |
|
|
| Section 16 Pulmonary |
|
|
47 Steroids for the Treatment of Croup |
|
|
307 | (4) |
|
|
|
|
|
48 Inhaled Corticosteroids for Mild Persistent Asthma: The START Trial |
|
|
311 | (6) |
|
|
|
|
|
49 Inhaled Salbutamol (Albuterol) versus Injected Epinephrine in Acute Asthma |
|
|
317 | (6) |
|
|
|
50 Long-term Inhaled Hypertonic Saline for Cystic Fibrosis |
|
|
323 | (6) |
|
|
| Index |
|
329 | |
